Developing New Therapies for Delta Hepatitis: The Race Is On
Genco Gençdal, Cihan Yurdaydin – 8 April 2021
Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors
Sunyoung Lee, Kyoung Won Kim, Jeongjin Lee, Taeyong Park, Hyo Jung Park, Gi‐Won Song, Sung‐Gyu Lee – 8 April 2021 – This study aimed to determine the factors associated with resolution of nonalcoholic fatty liver (NAFL) after lifestyle intervention in potential living liver donors as assessed by the gold standards in a longitudinal setting.
Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
Weiguo Fan, Natalie J. Torok – 8 April 2021
Left Lobe Living Donor Graft Could Be a Good Choice for Liver Transplantation
Toru Ikegami, Koichiro Haruki, Kenei Furukawa, Shinji Onda – 8 April 2021
Letter to the Editor: Use of New Defined Metabolic Risk Factors in Patients With Chronic Hepatitis B
Yanqing Liu, Shanshan Wang, Liqing Hu – 7 April 2021
Letter to the Editor: The Potential Mechanism by the Protection Effects of Exercise Training on Ischemia/Reperfusion–Induced Injury and Metastasis
Shang Longcheng, Wang Shuai, Liu Hanyi, Ren Haozhen, Shi Xiaolei – 7 April 2021
Letter to the Editor: Is Balloon‐Occluded Retrograde Transvenous Obliteration Superior to Endoscopic Cyanoacrylate in Gastric Varices?
Krishna Kumar Chinnadurai, Arka De, Ajay Duseja, Virendra Singh – 7 April 2021
Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy
Yosuke Osawa, Hironari Kawai, Tomoyuki Tsunoda, Haruki Komatsu, Miku Okawara, Yuriko Tsutsui, Yuichi Yoshida, Shiori Yoshikawa, Taizo Mori, Taiji Yamazoe, Sachiyo Yoshio, Takashi Oide, Ayano Inui, Tatsuya Kanto – 7 April 2021 – Congestive hepatopathy (CH) with chronic passive congestion is characterized by the progression of liver fibrosis without prominent inflammation and hepatocellular damage. Currently, the lack of reliable biomarkers for liver fibrosis in CH often precludes the clinical management of patients with CH.
Group‐2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2‐Neutrophil‐Induced Immunosuppression
Xingyuan Xu, Longyun Ye, Qi Zhang, Hang Shen, Shanshan Li, Xiaoyu Zhang, Mao Ye, Tingbo Liang – 7 April 2021
Biological Nanotherapeutics for Liver Disease
Julia Driscoll, Cody Wehrkamp, Yu Ota, Jonathan N. Thomas, Irene K. Yan, Tushar Patel – 6 April 2021 – Extracellular vesicles (EVs) are a heterogeneous group of biological nano‐sized vesicles that are released from cells and contribute to intercellular communication. Emerging knowledge about their biogenesis, composition, release, and uptake has resulted in broad interest in elucidating their potential roles in disease pathophysiology.